Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Avai Bio (AVAI) Cost of Revenue (2020 - 2025)

Avai Bio's Cost of Revenue history spans 2 years, with the latest figure at $213912.0 for Q4 2022.

  • On a quarterly basis, Cost of Revenue changed N/A to $213912.0 in Q4 2022 year-over-year; TTM through Mar 2023 was $817754.0, a N/A change, with the full-year FY2025 number at $85164.0, up 182.53% from a year prior.
  • Cost of Revenue hit $213912.0 in Q4 2022 for Avai Bio, up from $102866.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for AVAI hit a ceiling of $500976.0 in Q4 2020 and a floor of $102866.0 in Q2 2022.